New study reveals crucial protein interactions in Duchenne Muscular Dystrophy, opening doors to more precise and effective ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...

Exciting news in the biotech industry as positive phase 2 results for sevasemten in BMD drive long-term investment potential ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...

Study results provide root explanations for how dystrophin functions on a molecular level, providing base-level insights into ...

A BOY who is battling a progressive muscle-wasting disease was supported by a performance at this year’s Henley Living Advent ...

The antisense oligonucleotides market is set to grow at a 6.6% CAGR, reaching $5.5 billion by 2033. Expanding applications in ...

The newly approved medicines in 2024 from Massachusetts companies range from a schizophrenia drug to a gene therapy for ...

“Sports mad” from an early age and with a particular passion for rugby, he also loved music and played the drums at home in ...

A groundbreaking study has shed light on the complex interactions between dystrophin, a protein critical to muscle stability, and its partner protein, dystrobrevin, offering new pathways for ...

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year. That’s 9% fewer than in 2023, but still an impressive tally. In the 2000s, ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...